Drug intelligence / Profile preview

[(3R)-7-nitro-1,2,3,4-tetrahydroisoquinolin-3-yl]methanol

Development stage: Unknown
Modality: Small Molecules

Overview

This compound is a small molecule belonging to the class of tetrahydroisoquinolines—tetrahydrogenated isoquinoline derivatives. Its molecular formula is C10H12N2O3 and it has an average mass of 208.21 Da. It is considered experimental and has not been approved for any medical use or indication. There are no known clinical trials or approved therapeutic applications as of now[1][5]. The compound may have potential biological activities as a member of the isoquinoline class but no specific mechanism of action or pharmacological target has been established in public databases[10].

Other names: [(3R)-7-nitro-1,2,3,4-tetrahydroisoquinolin-3-yl]methanol[(3R)-7-Nitro-1,2,3,4-tetrahydro-3-isoquinolinyl]methanol

Beyond the preview

Go deeper on [(3R)-7-nitro-1,2,3,4-tetrahydroisoquinolin-3-yl]methanol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on [(3R)-7-nitro-1,2,3,4-tetrahydroisoquinolin-3-yl]methanol.

Explore the full profile